Tomasz Blicharski Lubelskie Centrum Diagnostyczne

Świdnik 21040

1 studies enrolling now · 6 studies all time

What they study most

Atopic Dermatitis, COVID-19, Coronary Heart Disease (CHD), Heart Failure, Heart Failure With Reduced Ejection Fraction, Systemic Lupus Erythematosus, Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight

Studies at this site

• Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction — Recruiting now
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight — Running, not enrolling
• Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). — Stopped early
• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participants With Systemic Lupus Erythematosus — Completed
• A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis — Stopped early